Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 10:11:956.
doi: 10.3389/fneur.2020.00956. eCollection 2020.

COVID-19-Related Anosmia: The Olfactory Pathway Hypothesis and Early Intervention

Alessandra Gori  1 , Fabrizio Leone  1 , Lorenzo Loffredo  2 , Bianca Laura Cinicola  1 , Giulia Brindisi  1 , Giovanna De Castro  1 , Alberto Spalice  3 , Marzia Duse  1 , Anna Maria Zicari  1
Affiliations

COVID-19-Related Anosmia: The Olfactory Pathway Hypothesis and Early Intervention

Alessandra Gori et al. Front Neurol. .

Abstract

Anosmia is a well-described symptom of Corona Virus Disease 2019 (COVID-19). Several respiratory viruses are able to cause post-viral olfactory dysfunction, suggesting a sensorineural damage. Since the olfactory bulb is considered an immunological organ contributing to prevent the invasion of viruses, it could have a role in host defense. The inflammatory products locally released in COVID-19, leading to a local damage and causing olfactory loss, simultaneously may interfere with the viral spread into the central nervous system. In this context, olfactory receptors could play a role as an alternative way of SARS-CoV-2 entry into cells locally, in the central nervous system, and systemically. Differences in olfactory bulb due to sex and age may contribute to clarify the different susceptibility to infection and understand the role of age in transmission and disease severity. Finally, evaluation of the degree of functional impairment (grading), central/peripheral anosmia (localization), and the temporal course (evolution) may be useful tools to counteract COVID-19.

Keywords: COVID-19; SARS-CoV-2; anosmia; olfactory bulb; olfactory receptors.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope. (2020) 130:1787 10.1002/lary.28692 - DOI - PMC - PubMed
    1. Suzuki M, Saito K, Min WP, Vladau C, Toida K, Itoh H, et al. . Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope. (2007) 117:272–7. 10.1097/01.mlg.0000249922.37381.1e - DOI - PMC - PubMed
    1. Durrant DM, Ghosh S, Klein RS. The olfactory bulb: an immunosensory effector organ during neurotropic viral infections. ACS Chem Neurosci. (2016) 7:464–9. 10.1021/acschemneuro.6b00043 - DOI - PMC - PubMed
    1. Moein ST, Hashemian SM, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty RL. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. (2020) 10:944–50. 10.1002/alr.22587 - DOI - PMC - PubMed
    1. Cherry G, Rocke J, Chu M, Liu J, Lechner M, Lund VJ, et al. . Loss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends. Expert Rev Anti Infect Ther. (2020) 1–6. 10.1080/14787210.2020.1792289 - DOI - PMC - PubMed